Publicaciones Imprimir Islam Jessica Y, Hathaway Cassandra A, Hume Emma, Turner Kea, Hallanger-Johnson Julie, Tworoger Shelley S, Camacho-Rivera Marlene. Racial and Ethnic Inequities in Cancer Care Continuity During the Covid-19 Pandemic among those with SARS-CoV-2 JAMA Network Open. 2024. Zhang Y, Darville L, Hogue S, Hallanger Johnson JE, Rose T, Kim Y, Bailey A, Gray JE, Robinson LA. High Pretreatment DHEA Is Associated with Inferior Immunotherapy Response in Metastatic Non-Small Cell Lung Cancer Cancers. 2024. Kansara B, Basta A, Mikhael M, Perkins R, Reisman P, Hallanger-Johnson J, Rollison DE, Nguyen OT, Powell S, Gilbert SM, Turner K. Suicide Risk Screening for Head and Neck Cancer Patients: An Implementation Study. Appl Clin Inform. 2024 Mar; 15 (2):404-413 Epub 2024 May 22 View PubMed Tarasova , Valentina D, Tsai , Jill, Massannat , Jude, Hernandez Prera , Juan C, Hallanger Johnson Julie, Veloski , Colleen, Agosto Salgado , Sarimar, McIver , Bryan, Drusbosky , Leylah M, Chung , Christine H. Characterization of the Thyroid Cancer Genomic Landscape by Plasma-Based Circulating Tumor DNA Next-Generation Sequencing Thyroid. 2024; 34:197-205. Saeed-Vafa D, Chatzopoulos K, Hernandez-Prera J, Cano P, Saller JJ, Hallanger Johnson JE, McIver B, Boyle TA. RET splice site variants in medullary thyroid carcinoma. Front Genet. 2024; 15:1377158 Epub 2024 Mar 19 View PubMed Al-Toubah T, Strosberg J, Hallanger-Johnson JE, El-Haddad G.. Targeted Radionuclide therapy in endocrine-related cancers: Advances in the last decade Frontiers in Endocrinology. 2023. Al-Toubah T, Pelle E, Hallanger-Johnson J, Haider M, Strosberg J. ACTH-secreting pancreatic neuroendocrine neoplasms: A case series. J Neuroendocrinology. 2023. Turner K, Stover AM, Tometich DB, Geiss C, Mason A, Nguyen OT, Hume E, McCormick R, Powell S, Hallanger-Johnson J, Patel KB, Kirtane KS, Jammigumpula N, Moore C, Perkins R, Rollison DE, Jim HSL, Oswald LB, Crowder S, Gonzalez BD, Robinson E, Tabriz AA, Islam JY, Gilbert SM. Oncology Providers' and Professionals' Experiences With Suicide Risk Screening Among Patients With Head and Neck Cancer: A Qualitative Study. JCO Oncol Pract. 2023 Jun; 19(6):e892-e903. Epub 2022 Nov 17. View PubMed Nguyen OT, Turner K, Charles D, Sprow O, Perkins R, Hong YR, Islam JY, Khanna N, Alishahi Tabriz A, Hallanger-Johnson J, Bickel Young J, Moore CE. Implementing Digital Scribes to Reduce Electronic Health Record Documentation Burden Among Cancer Care Clinicians: A Mixed-Methods Pilot Study. JCO Clin Cancer Inform. 2023 Mar; 7:e2200166. View PubMed Padua TC, Marandino L, Raggi D, Hallanger-Johnson J, Kutikov A, Spiess PE, Necchi A. A Systematic Review of Published Clinical Trials in the Systemic Treatment of Adrenocortical Carcinoma: An Initiative Led on Behalf of the Global Society of Rare Genitourinary Tumors. Clin Genitourin Cancer. 2023 Feb; 21 (1):1-7 Epub 2022 Oct 23 View PubMed Hallanger Johnson J, El-Haddad G. Letter to the Editor From Hallanger Johnson and El-Haddad: "Yttrium-90 Selective Internal Radiation Therapy Plus Cryoablation for Recurrent Adrenocortical Carcinoma With Liver Metastases". J Endocr Soc. 2022 Oct 26; 6 (12):bvac154 Epub 2022 Oct 06 View PubMed Turner K, Bobonis Babilonia M, Naso C, Nguyen O, Gonzalez BD, Oswald LB, Robinson E, Elston Lafata J, Ferguson RJ, Alishahi Tabriz A, Patel KB, Hallanger-Johnson J, Aldawoodi N, Hong YR, Jim HSL, Spiess PE. Health Care Providers' and Professionals' Experiences With Telehealth Oncology Implementation During the COVID-19 Pandemic: A Qualitative Study. J Med Internet Res. 2022 Jan 19; 24 (1):e29635 View PubMed Naffouje SA, Sabesan A, Hallanger-Johnson J, Kirtane K, Gonzalez RJ, Mullinax J. Adrenal biopsy, as a diagnostic method, is associated with decreased overall survival in patients with T1/T2 adrenocortical carcinoma: A propensity score-matched analysis. J Surg Oncol. 2021 Dec; 124 (8):1261-1271 Epub 2021 Aug 23 View PubMed Lu S, Dhillon J, Hallanger Johnson J, Johnson JH, El-Haddad G. Yttrium-90 radioembolization of isolated hepatic adrenocortical carcinoma metastases with negative surgical pathology. EJNMMI Res. 2021 Feb 18; 11 (1):17 View PubMed Seok , K, Hallanger Johnson J, Holmstrom , B, Hembree , T, Ramsakal A, Verma N. Literally Malignant Hypertension SN Compr. Clin. Medhttps://dotnetprod.mayo.edu/reaims/web/Publications/PublicationCreate#authors. 2021; (3):1960-1964. Keerty D, Das M, Hallanger-Johnson J, Haynes E. Diabetic Ketoacidosis: An Adverse Reaction to Immunotherapy Cureus. 2020; 12(9). Pereira M, Williams V, Hallanger Johnson J, Valdarrabano Pablo. Thyroid Cancer Incidence Trends in the United States: Association with Changes in Professional Guidelines Thyroid. 2020; 8:1132-1140. Epub 2020 Apr 03. Hernandez-Prera JC, Valderrabano P, Creed JH, de la Iglesia JV, Slebos RJC, Centeno BA, Tarasova V, Hallanger-Johnson J, Veloski C, Otto KJ, Wenig BM, Yoder SJ, Lam CA, Park DS, Anderson AR, Raghunand N, Berglund A, Caudell J, Gerke TA, Chung CH. Molecular Determinants of Thyroid Nodules with Indeterminate Cytology and RAS Mutations. Thyroid. 2020. Ehab J, Hallanger-Johnson J, Gonzalez G, Suz P, Kis B, Anaya D. Resection of Adrenocortical Carcinoma with Bilobar Liver Metastasis Following Neoadjuvant Therapy Using a Modified Mini-ALPPS Approach: A Case Report International Journal of Surgical Case Reports. 2020; 2(1):1-5. Hallanger Johnson J. Systemic therapy for adrenocortical carcinoma: A review AME Medical Journal. 2020. Valderrabano P, Hallanger J, Thapa R, Wang X, McIver B. Comparison of postmarketing findings versus the initial clinical validation findings of a thyroid nodule gene expression classifier: A systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg.. 2019. Valderrabano P, Khazai L, Thompson ZJ, Leon ME, Otto KJ, Hallanger-Johnson JE, Wadsworth JT, Chung CH, Centeno BA, McIver B. Impact of oncogene panel results on surgical management of cytologically indeterminate thyroid nodules. Head & Neck. 2018; 40(8):1812-1823. Epub 2018 Apr 06. Valderrabano P, Khazai L, Thompson ZJ, Sharpe SC, Tarasova V, Otto KJ, Hallanger-Johnson JE, Wadsworth JT, Wenig BM, Chung CH, Centeno BA, McIver B.. Cancer Risk Associated with Nuclear Atypia in Cytologically Indeterminate Thyroid Nodules: A Systematic Review and Meta-Analysis. Thyroid. 2018; 2:210-219. Valderrabano P, Khazai L, Thompson ZJ, Otto KJ, Hallanger-Johnson JE, Chung CH, Centeno BA, McIver B.. Association of Tumor Size with Histological and Clinical Outcomes Among Patients with Cytologically Indeterminate Thyroid Nodules JAMA Otolaryngol Head Neck Surg. 2018. Valderrabano P, Khazai L, Thompson ZJ, Ma Z, Leon ME, Otto KJ, Hallanger-Johnson J, Wadsworth JT, Wenig BM, Chung CH, Centeno BA. Cancer risk stratification of indeterminate thyroid nodules: A cytological approach. Thyroid. 2017; 10:1277-1284. Evaluation of ThyroSeq v2 Performance in Thyroid Nodules with Interdeterminate Cytology. Endocr Relat Cancer. 2017; 3:127-136. Reddi HV, Driscoll CB, Madde P, Milosevic D, Hurley RM, McDonough SJ, Hallanger-Johnson J, McIver B, Eberhardt NL. Redifferentiation and induction of tumor suppressors miR-122 and miR-375 by the PAX8/PPARgamma fusion protein inhibits anaplastic thyroid cancer: a novel therapeutic strategy. Cancer Gene Ther. 2013 May; 20(5):267-75. Epub 2013 Apr 19. View PubMed Khoo TK, Baker CH, Hallanger-Johnson J, Tom AM, Grant CS, Reading CC, Sebo TJ, Morris JC 3rd. Comparison of ultrasound-guided fine-needle aspiration biopsy with core-needle biopsy in the evaluation of thyroid nodules. Endocr Pract. 2008 May-Jun; 14 (4):426-31 View PubMed Hallanger Johnson JE, Kearns AE, Doran PM, Khoo TK, Wermers RA. Fluoride-related bone disease associated with habitual tea consumption. Mayo Clin Proc. 2007 Jun; 82 (6):719-24 View PubMed PST-20561285 Inicio Publicaciones